Clinical Trial Update: Rituximab in Hairy Cell Leukemia: a Multicenter Retrospective Study

View source ↗

Summary

A multicenter retrospective study evaluates the use of rituximab in hairy cell leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hairy Cell Leukemia

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: CHU de Reims | Conditions: Hairy-cell Leukemia | Status: COMPLETED